Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

S David Miller

Allergy & Immunology North Dartmouth, MA Medical Doctor

NPI 1063471126 CMS profile 48602

49 State Rd, Watuppa Building Suite 203, North Dartmouth, MA 02747

Open in the dashboard

General payments

$12,932

227 records reported · program years 2019–2024

Research payments

$5,051

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$8,663,981 paid to institutions, not to them · program years 2019–2025

Through program year 2024, S David Miller of North Dartmouth, MA is reported in the CMS Open Payments database as having received $12,932 across 227 general payments and $5,051 in research payments paid to them. Separately, studies naming them as principal investigator received $8,663,981 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $168 1
2024 Research $5,051 1
2023 General $3,801 20
2022 General $1,353 12
2021 General $1,558 74
2020 General $2,191 51
2019 General $3,861 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • S David Miller
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to S David Miller were reported at $0. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year S David Miller Allergy & Immunology median Middle half National median
2019 $3,861 $594 $163–$1,512 $163
2020 $2,191 $426 $106–$1,233 $114
2021 $1,558 $638 $157–$1,708 $132
2022 $1,353 $790 $205–$1,961 $149
2023 $3,801 $852 $220–$2,147 $160
2024 $168 $865 $203–$2,267 $164
2025 $0 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. AstraZeneca Pharmaceuticals LP $5,482 72 payments
  2. Mylan Inc. $2,490 2 payments
  3. AstraZeneca UK Limited $1,985 10 payments
  4. GlaxoSmithKline, LLC. $776 41 payments
  5. Genzyme Corporation $241 11 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $211 10 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $190 10 payments
  8. Cipla USA Inc. $168 1 payment
  9. CSL Behring $159 8 payments
  10. kaleo, Inc. $131 7 payments
  11. Other $1,097 55 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $4,985 207 payments
  2. Travel and Lodging $4,359 15 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,658 3 payments
  4. Consulting Fee $930 2 payments
Products named General payments · program years 2019–2024
  1. BREZTRI $2,991 25 payments
  2. Wixela Inhub $2,490 2 payments
  3. BEVESPI AEROSPHERE $1,905 23 payments
  4. TRELEGY ELLIPTA $375 19 payments
  5. CUVITRU $279 19 payments
  6. NUCALA $275 15 payments
  7. FASENRA $255 10 payments
  8. NURTEC ODT $246 4 payments
  9. DUPIXENT $204 9 payments
  10. SPIRIVA RESPIMAT $203 11 payments
  11. Other $1,584 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Amphastar Pharmaceuticals, Inc. $5,051 1 payment

Records

228 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record